To the full analysis
Icade stock: growth
ICAD.PAIcade reported $1.61B in revenue for fiscal 2025, down 0.1% on the prior year, up 0% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
0.5%
per year from 2006 to 2025, per share −2.8%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 0.0% | 0.1% | 0.5% |
| Revenue per share | −0.5% | −0.2% | −2.8% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $1.47B | $249.88M | −$56.96M |
| 2007 | $1.66B | $40.89M | −$547.96M |
| 2008 | $1.79B | $346.28M | −$955.63M |
| 2009 | $1.67B | $584.08M | −$208.66M |
| 2010 | $1.59B | $1.35B | −$424.73M |
| 2011 | $1.65B | $103.05M | −$559.7M |
| 2012 | $1.66B | $57.07M | −$384.62M |
| 2013 | $1.61B | $140.62M | −$201.67M |
| 2014 | $1.91B | $167.88M | −$220.4M |
| 2015 | $1.59B | −$207.33M | −$363.46M |
| 2016 | $1.65B | $49.53M | −$681.15M |
| 2017 | $1.81B | $183.39M | −$377.31M |
| 2018 | $1.96B | $171.64M | −$187.38M |
| 2019 | $1.69B | $332.65M | −$461.97M |
| 2020 | $1.6B | $88.09M | $132.42M |
| 2021 | $1.83B | $443.35M | −$551.39M |
| 2022 | $1.74B | $59.95M | −$259.52M |
| 2023 | $1.69B | −$1.39B | $20.28M |
| 2024 | $1.61B | −$305.72M | $184.17M |
| 2025 | $1.61B | −$136.3M | −$5.65M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 30 Apr 2023)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.